How News Agencies’ Twitter Posts on COVID-19 Vaccines Attract Audiences’ Twitter Engagement: A Content Analysis

Author:

Wang DiORCID,Lu JiahuiORCID

Abstract

As the most important global news distributors, the big three international news agencies’ reports about COVID-19 vaccines have a great influence on people’s understanding of them. Based on the health belief model (HBM), we examined which constructs in the HBM were related to audiences’ Twitter engagement and the differences among the agencies. We content-analyzed 1162 COVID-19 vaccine-related tweets from three international news agencies’ Twitter accounts (@AFPespanol, @AP, @Reuters) from 2 December 2020 to 31 January 2021. The results showed that the most-used HBM construct was barriers, followed by benefits, susceptibility, cues to action, severity, and self-efficacy. About half of the tweets used a positive tone and nearly half of the tweets used a neutral tone, while only 3.1% of the tweets used a negative tone. Reuters used a significantly more negative tone, more neutral tone, and less positive tone than was expected. AFP used a significantly more positive tone and less neutral tone than was expected. The effectiveness of utilizing HBM constructs for vaccination promotion strongly depends on the audience context. The use of HBM constructs for vaccination was generally effective for Reuters but seems to have backfired for AFP.

Funder

The Higher Education Fund of the Macao S.A.R. Government

Publisher

MDPI AG

Subject

Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health

Reference59 articles.

1. A comparative study of public health and social measures of COVID-19 advocated in different countries

2. The UK has Approved a COVID Vaccine—Here’s What Scientists Now Want to Knowhttps://www.nature.com/articles/d41586-020-03441-8

3. FDA Authorizes 1st COVID-19 Vaccine in United Stateshttps://abcnews.go.com/Health/fda-authorizes-1st-covid-19-vaccine-united-states/story?id=74665712

4. EMA Recommends First COVID-19 Vaccine for Authorisation in the EUhttps://www.ema.europa.eu/en/news/ema-recommends-first-covid-19-vaccine-authorisation-eu

5. COVID-19: China Approves Sinopharm Vaccine for General Usehttps://www.bbc.com/news/world-asia-china-55498197

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3